These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2764686)

  • 1. [Posology of amikacin in newborn infants, adapted to the postconceptional age].
    Rozé JC; Tohier C; Rigal E; Drugeon B; Mouzard A
    Arch Fr Pediatr; 1989 May; 46(5):375-9. PubMed ID: 2764686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amikacin dosing in neonates: evaluation of a dosing chart based on population pharmacokinetic data.
    Petersen PO; Wells TG; Kearns GL
    Dev Pharmacol Ther; 1991; 16(4):203-11. PubMed ID: 1782838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of amikacin in pony foals after a single intramuscular injection.
    Brown MP; Gronwall RR; Martinez DS; Beal C
    Am J Vet Res; 1986 Feb; 47(2):453-4. PubMed ID: 3954234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD; Ling GV; Chatfield RC
    Am J Vet Res; 1985 Aug; 46(8):1793-6. PubMed ID: 4037511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amikacin sulfate in mares: pharmacokinetics and body fluid and endometrial concentrations after repeated intramuscular administration.
    Brown MP; Embertson RM; Gronwall RR; Beal C; Mayhew IG; Curry SH
    Am J Vet Res; 1984 Aug; 45(8):1610-3. PubMed ID: 6476574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adaptation of amikacin dosages for the premature infant].
    Palix C; Charbit-Bues M; Coignet J; Cano JP
    Pediatrie; 1986 Mar; 41(2):147-57. PubMed ID: 3774426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the administration of amikacin by intramuscular and intravenous routes in neonatal resuscitation].
    Deramoudt-Dutrus V; Betremieux P; Lefrançois C; Malledant Y; Avril JL; Le Marec B
    Pediatrie; 1989; 44(2):125-32. PubMed ID: 2654876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin pharmacokinetics and the effects of ambient temperature on the dosage regimen in ball pythons (Python regius).
    Johnson JH; Jensen JM; Brumbaugh GW; Boothe DM
    J Zoo Wildl Med; 1997 Mar; 28(1):80-8. PubMed ID: 9226620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of intrauterine maturation on the pharmacokinetics of amikacin in the neonatal period.
    Assael BM; Parini R; Rusconi F; Cavanna G
    Pediatr Res; 1982 Oct; 16(10):810-5. PubMed ID: 7145504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant.
    Kenyon CF; Knoppert DC; Lee SK; Vandenberghe HM; Chance GW
    Antimicrob Agents Chemother; 1990 Feb; 34(2):265-8. PubMed ID: 2327775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age.
    van den Anker JN; Schoemaker RC; Hop WC; van der Heijden BJ; Weber A; Sauer PJ; Neijens HJ; de Groot R
    Clin Pharmacol Ther; 1995 Dec; 58(6):650-9. PubMed ID: 8529330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of prematurity on tear production.
    Akar Y; Cira A; Apaydin C; Erman MA; Yilmaz A
    Curr Eye Res; 2004 Feb; 28(2):145-51. PubMed ID: 14972720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Penetration of amikacin into the anterior chamber of the human eye].
    Barrera V; Sinues B; Martinez P; Buatas A; Pinero A
    J Fr Ophtalmol; 1984; 7(8-9):539-43. PubMed ID: 6520334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group.
    Zubrow AB; Hulman S; Kushner H; Falkner B
    J Perinatol; 1995; 15(6):470-9. PubMed ID: 8648456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended amikacin doses in newborns often produce excessive serum levels.
    Philips JB; Satterwhite C; Dworsky ME; Cassady G
    Pediatr Pharmacol (New York); 1982; 2(2):121-5. PubMed ID: 12760404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment.
    Moffett BS; Cannon BC; Friedman RA; Kertesz NJ
    Pharmacotherapy; 2006 Dec; 26(12):1687-93. PubMed ID: 17125432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA; Sinaniotis CA; Papadatos CJ; Kosmidis J
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.